Characteristic | Details |
---|---|
Active Ingredients | Tadalafil 20mg, Sildenafil 100mg |
Formulation | Oral Tablet |
Route of Administration | Oral |
Onset of Action | 30-60 minutes |
Duration of Effect | Up to 36 hours |
Learn More About Sildalis |
Pharmacokinetics
Sildalis combines two powerful phosphodiesterase inhibitors: Sildenafil 100mg and Tadalafil 20mg. These ingredients enhance erectile function through distinct yet synergistic mechanisms. Sildenafil achieves peak plasma concentration within 30 to 120 minutes post-ingestion. It has a terminal half-life of about 4 hours. Tadalafil, on the other hand, reaches peak plasma levels within 2 hours and exhibits a half-life extending up to 17.5 hours, contributing to its prolonged effect.
The metabolism of these agents primarily occurs in the liver, mediated by the CYP3A4 isoenzyme. Elimination pathways for both involve renal and fecal excretion, highlighting the importance of liver and kidney health for effective clearance. Sildalis' dual-action results in enhanced efficacy with a broader temporal window, favoring its use in various therapeutic contexts.
Areas of Use
Sildalis is primarily indicated for erectile dysfunction. Its unique combination offers benefits to those who require longer-lasting results. Patients with psychogenic or organic etiologies benefit from its dual mechanism. The tadalafil component ensures sustained action, reducing the need for repeated dosing within a short time frame.
Beyond its primary indication, Sildalis has shown promise in addressing certain cases of pulmonary arterial hypertension, where tadalafil is particularly effective. Its role in improving exercise capacity by modulating pulmonary vascular resistance is under continuous examination. Clinical trials expand its application to additional vascular-related disorders.
Warning & Precautions
Users must consider contraindications associated with Sildalis. Nitrates or nitric oxide donors must not be combined due to risks of severe hypotension. Conditions such as severe cardiovascular disorders, recent myocardial infarction, or stroke warrant caution. Pre-existing retinal disorders like retinitis pigmentosa can exacerbate risks.
Before initiating treatment, comprehensive cardiovascular assessment is essential. Those with hepatic or renal impairment require dose adjustment. Alcohol consumption might increase adverse reactions. Users should monitor for signs of prolonged erection exceeding 4 hours, necessitating immediate medical attention.
Missed Dose
Adhering to dosing schedules enhances Sildalis' effectiveness. If a dose is missed, it should be taken promptly unless the next scheduled dose is imminent. Double dosing should be avoided to mitigate risk of overdose. Consistent administration timing aligns therapeutic windows optimally.
How to Cope with Side Effects of Sildalis
Common side effects include headaches, flushing, and dyspepsia. Staying hydrated and using mild analgesics helps manage headaches. Flushing usually resolves without intervention. Gastrointestinal discomfort may decrease with food intake, albeit with slower absorption.
Serious adverse events like visual disturbances, chest pain, or significant drops in blood pressure necessitate immediate cessation of use and medical consultation. Monitoring individual reactions enables prompt addressing of complications, ensuring safer use.
Where to Buy Sildalis Online
Purchasing Sildalis through verified online platforms ensures authenticity and safety. Pharmacies with transparent sourcing and stringent verification processes offer the best assurance. Verify regulatory approval before committing to any transaction.
Reputable online sources provide detailed product information, including active ingredients and pharmacological profiles. Customer reviews serve as indicators of service reliability. Due diligence protects against counterfeit risks, optimizing the therapeutic experience.
Feature | Description |
Active Duration | Up to 36 hours |
- Enhanced erectile function
- Dual action mechanism
- Long-lasting effects
- Useful for pulmonary arterial hypertension